Adult articular cartilage presents poor intrinsic capacity for regeneration, and after injury, cellular or biomaterial-based therapeutic platforms are required to assist repair promotion. Cartilage tissue engineering (CTE) aims to produce cartilage-like tissues that recreate the complex mechanical, biophysical and biological properties found in vivo. In terms of biomaterials used for CTE, three-dimensional (3D) self-assembling peptide scaffolds (SAPS) are very attractive for their unique properties, such as biocompatibility, optional possibility of rationally design cell-signaling capacity, biodegradability and modulation of its biomechanical properties. The most attractive cell types currently used for CTE are autologous chondrocytes and adult stem cells. The use of chondrocytes in cell-based therapies for cartilage lesions is limited by quantity and requires an in vitro 2D expansion, which leads to cell dedifferentiation. In the present chapter, we report the development of heparin-, chondroitin sulfate-, decorin-, and poly(ε-caprolactone)-based self-assembling peptide composite scaffolds to promote re-differentiation of expanded human articular chondrocytes and induction of adipose-derived stem cells to chondrogenic commitment.
- 3D cell culture
- self-assembling peptide scaffold
- biomimetic materials
- tissue engineering
Articular cartilage is an avascular connective tissue, composed of chondrocytes as practically unique cell type. Articular chondrocytes synthesize, maintain and remodel the highly specialized extracellular matrix (ECM) , which in turn allows to withstand the mechanical requirements of the joints . It is currently believed that due to its avascular nature, cartilage tissue lacks an intrinsic capacity for regeneration in response to disease or injury, leading to long-term pain, degeneration and loss of function . Cartilage tissue engineering (CTE) aims to produce cartilage-like tissue substitutes by combining the appropriate cells, scaffolds and bioactive molecules to assist repair cartilage lesions [4, 5].
Cell types currently used for CTE include autologous articular chondrocytes (ACh), which already possess the desired phenotype, and mesenchymal stem cells (MSC), from bone marrow (BMSC) or adipose tissue-derived (ADSC), which can be induced to undergo chondrogenic differentiation [6, 7]. Autologous chondrocytes would be the ideal cell source for cartilage repair due to their intrinsic properties regarding cell function and immune compatibility. However, cell accessibility from a patient biopsy is limited, and once isolated, chondrocytes needs to be extensively expanded in 2D monolayer . During expansion process, chondrocytes rapidly undergo extensive loss of the original tissue-specific phenotype, downregulating the expression of chondrogenic markers, such as collagens and glycosaminoglycans while acquiring a fibroblast-like phenotype [8, 9].
Three-dimensional (3D) culture platforms are currently used to restore or maintain chondrogenic phenotype, since it recreates more closely the complex cellular microenvironment found
Synthetic hydrogels are good candidates for CTE since they possess unique properties, such as more than 95% of water content (which mimics the native cartilage ECM), biocompatibility and capacity of rationally design chemical signaling and biochemical properties. One of the best examples is the self-assembling peptide scaffold RAD16-I, commercially available as Puramatrix™. RAD16-I is a short peptide constituted by the sequence AcN-(RADA)4-CONH2, which alternates hydrophilic and hydrophobic amino acids (Figure 1A) . The peptide undergoes self-assembly into a nanofiber network with antiparallel β-sheet configuration under physiological conditions (Figure 1B) . The nanoscale architecture of the fiber network (around 10 nm diameter and 50–200 nm pore size) allows the cells to experiment a truly 3D environment (Figure 1C). Besides, biomolecules in such nanoscale environment diffuse slowly and are likely to establish a local molecular gradient. Non-covalent interactions allow cell growth, migration, contact with other cells, shape changes and a properly exposition of membrane receptors. Moreover, since stiffness can be controlled by changing peptide concentration these hydrogels can be tuned up to embed cells but not to entrap them .
Since the peptide scaffold does not contain signaling motifs, the environment can be considered non-instructive, from the point of view of cell receptor recognition/activation. However, the self-assembling peptide scaffold RAD16-I can be functionalized by solid-phase synthesis by extending at the N-termini with signaling motifs, such as ECM ligands for cell receptors, to trigger different cellular responses [16, 19]. Several studies showed the capacity of RAD16-I to support cell maintenance of multiple cell types, including endothelial cells , hepatocytes [19, 21], fibroblasts , embryonic  and somatic stem cells [24, 25].
In the present chapter, we report the development of new bicomponent scaffolds based on the self-assembling peptide RAD16-I, for guiding chondrogenic differentiation of both adipose-derived stem cells (ADSC) and expanded dedifferentiated human articular chondrocytes (hAChs).
On one hand, we took advantage of the versatility of RAD16-I to specifically add molecular cues for guiding chondrogenesis in order to develop more biomimetic scaffolds. Thus, the first approach was based on the addition of heparin (Hep) moieties to the peptide scaffold, forming a stable electrostatic-based composite made of heparin-self-assembling peptide hydrogel. The advantage of this bicomponent scaffold is its natural capacity to retain heparin binding domain (HBD) containing growth factors (GFs), and thus, protecting them from degradation or denaturation . Therefore, the non-instructive RAD16-I scaffold provides the structural 3D environment while the heparin moiety the binding structure to HBD-containing GFs. Our second approach, was based on mimicking the native articular cartilage ECM while providing signaling moieties presented in mature cartilage. Glycosaminoglycans (GAGs) and proteoglycans (PGs) are structural components of the native cartilage ECM and influence the regulation of cell proliferation, migration and differentiation . In particular, chondroitin sulfate (CS, a sulfated GAG usually found as a constituent of PGs) and decorin (a small PG, consisting of a protein core linked to a GAG chain, consisting of chondroitin sulfate or dermatan sulfate) [27, 28] molecules were added to the RAD16-I scaffold by mixing the components, obtaining a chondroitin sulfate- and decorin-based self-assembling peptide composite scaffold.
Finally, we combined the self-assembling peptide RAD16-I with a woven poly(ε-caprolactone) (PCL). 3D weaving can be used to create porous structures arranged in multiple layers of continuous fibers in three orthogonal directions . Such scaffolds were engineered with predetermined properties aiming to reproduce the mechanical features of native articular cartilage. Moreover, PCL is a Food and Drug Administration (FDA) approved biomaterial, biocompatible and biodegradable, widely used for medical applications [30, 31]. Our strategy was based on combine these two biomaterials to promote the attachment and differentiation of embedded cells, providing at the same time a biomimetic mechanical environment of the native mature cartilage .
2. Materials and methods
2.1 2D culture of ADSC and hACh
ADSC (PT-5006, Lonza) were cultured in 175 cm2 T-flasks (<6th passage) in Adipose-Derived Stem Cell Basal Medium (ADSC-BM) (PT-3273, Lonza) supplemented with Adipose-Derived Stem Cell Growth Medium (ADSC-GM) SingleQuots (PT-4503, Lonza). hACh cells (CC-2550, Lonza) were cultured at 10,000 cells/cm2 from passages 2–6 in 25, 75, and 175 cm2 T flasks. The growth medium consisted of Chondrocyte Basal Medium (CBM) (CC-3217, Lonza) plus SingleQuots of Growth Supplements (CC-4409, Lonza) containing R3-IGF-1, bFGF, transferrin, insulin, FBS, and gentamicin/amphotericin-B. Cultures were maintained in the incubator in humidified atmosphere at 37°C and 5% CO2.
2.2 3D culture of ADSC and hACh in RAD16-I composites scaffolds
ADSC and hACh 3D cultures were maintained under control or chondrogenic conditions. Control medium was prepared with DMEM High Glucose, GlutaMAX (61965, Gibco), ITS + Premix 100x (354352, BDBioscience), 100 U/mL Penicillin/100 μg/mL Streptomycin (P11-010, PAA), 40 μg/mL l-Proline (P5607, Sigma) and 1 mM Sodium Pyruvate (11360, Life Technologies). Cultures for chondrogenic differentiation were induced at day 2 with chondrogenic medium (control medium supplemented with 10 ng/mL TGFβ1 (GF111, Millipore), 25 μg/mL l-ascorbic acid 2-phosphate (A8960; Sigma) and 100 nM Dexamethasone (D8893; Sigma)). Chondrocytes were also cultured in expansion medium (see Section 2.1). 3D cell cultures were maintained in the incubator at 37°C and 5% CO2, and medium was changed every other day. Cultures were maintained for 4 weeks in the described serum-free media under control or chondrogenic conditions (in the presence of stimulating factors to induce chondrogenic differentiation) [33, 34]. After 4 weeks, 3D constructs were analyzed for morphology, gene and protein expression, glycosaminoglycans production and mechanical properties.
2.3 ADSC 3D culture in RAD/heparin composite scaffold
RAD16-I (PuraMatrix™, 354250, Corning) and composites RAD/Hep were prepared at a final concentration of 0.3% (w/v) RAD16-I. The composites were prepared by combining 95 μL of 0.5% (w/v) RAD16-I and 5 μL of heparin sodium salt solution (H3149, Sigma) in a concentration range between 0.01% and 1% (w/v). The mixture was then diluted with 10% sucrose (S0389, Sigma) to a final concentration of 0.3% (w/v) RAD16-I. To obtain RAD and RAD/Hep 3D cultures, ADSC were harvested by trypsinization and resuspended to 4 × 106 cells/mL in 10% sucrose. The 0.3% (w/v) RAD16-I peptide solution was mixed with the cell suspension (1:1) to obtain a final concentration of 0.15% (w/v) RAD16-I and 2 × 106 cells/mL. Then, 80 μL of the cell-peptide mixture (160,000 cells) was loaded into individual wells of a 48-well culture containing 150 μL of medium, which induced the self-assembly of the peptide. The plate was placed in the incubator for 20 min at 37°C and 5% CO2, and then 650 μL of fresh medium was added to the 3D cell cultures. ADSC 3D cultures were maintained during 2 days under control medium. Cultures for chondrogenic differentiation were induced at day 2 with chondrogenic medium.
2.3.1 ADSC and hACh 3D culture in RAD/CS and RAD/Dec composite scaffold
RAD16-I (PuraMatrix™, 354250, Corning) and composites RAD/CS and RAD/Decorin were prepared at a final concentration of 0.3% (w/v) RAD16-I. The composites were prepared by combining 95 μL of 0.5% (w/v) RAD16-I and 5 μL CS or Decorin at a concentration of 0.2% (w/v). The mixture was then diluted with 10% sucrose (S0389, Sigma) to a final concentration of 0.3% (w/v) RAD16-I. To obtain RAD16-I, RAD/CS and RAD/Decorin 3D cultures, cells were harvested by trypsinization and resuspended to 4 × 106 cells/mL in 10% sucrose. The 0.3% (w/v) RAD16-I peptide solution was mixed with the cell suspension (1:1) to obtain a final concentration of 0.15% (w/v) RAD16-I and 2 × 106 cells/mL. Then, 80 μL of the cell-peptide mixture (160,000 cells) was loaded into individual wells of a 48-well culture containing 150 μL of control or expansion medium, which induced the self-assembly of the peptide. The plate was placed in the incubator for 20 min at 37°C and 5% CO2, and then 650 μL of fresh medium was added to the 3D cell cultures.
2.3.2 hACh 3D culture in PCL, PCL/RAD and RAD scaffolds
In the case of PCL scaffold, a cell suspension of 25 × 106 cells/mL was seeded onto the surface of 5 mm × 0.75 mm woven PCL scaffolds (500,000 cells/scaffold). After 2 h, 100 μL of expansion or control medium were slowly added into the well and after 4 h, 700 μL were finally added. For PCL/RAD composites, cells were harvested and resuspended to 50 × 106 cells/mL in 10% (w/v) sucrose. Then, cells were equally mixed with 1% (w/v) RAD16-I and seeded onto the woven PCL scaffold disks (500,000 cells/scaffold). Then, 40 μL of expansion or control medium was added and the gel was spontaneously formed inside the PCL scaffolds, where the cells were embedded. After 30 min, 60 μL of medium was added in the well, and after 2 h, 700 μL was finally added. 3D cell cultures were maintained in the incubator at 37°C and 5% CO2, and medium was changed every other day.
3. Representative results
Autologous chondrocytes are one of the most attractive cell types for CTE, due to their intrinsic properties regarding cell function, since they are found in the native cartilage. Chondrocytes are characterized by a rounded morphology, the production of tissue-specific ECM components such as collagen type I and II and glycosaminoglycans (GAGs). One of the main challenges in CTE is to obtain enough cell mass to develop a tissue construct with the desirable biological and biomechanical properties. Particularly, articular chondrocytes are obtained by invasive techniques and cell number in patient biopsies is limited. Therefore, after isolation, chondrocytes need to be expanded in 2D monolayer . The expansion process leads to a rapid downregulation of chondrogenic markers, such as Collagen type I (COL1) collagen type II (COL2) and Aggrecan (ACAN) [8, 9]. Moreover, the use of extensively passaged cells leads to some degree of hypertrophy, decreased biochemical content and compromised mechanical properties , which is not a good indication for cartilage substitute applications.
Mesenchymal stem cells (MSCs) have generated great interest as an alternative cell source to autologous chondrocytes. MSCs are pluripotent cells with a high proliferative capacity that can be differentiated, under the appropriate microenvironment, to numerous cell lineages, such as osteogenic, adipogenic and chondrogenic . MSCs can be isolated from bone marrow, adipose tissue and other sources. In particular, the adipose tissue provides and abundant reservoir of mesenchymal stem cells (adipose-derived stem cells, ADSC), which can be obtained by non-invasive surgical techniques. ADSC can undergo chondrogenic commitment in the presence of TGF-β, ascorbate, and dexamethasone combined with a 3D culture environment .
Three-dimensional scaffold-based cell cultures are currently used in CTE to reestablish chondrogenic phenotype of dedifferentiated chondrocytes, since they mimic more closely the natural tissue environment. On the other hand, differentiation of ADSC to cartilage-like tissue has been achieved in various 3D scaffold systems such as alginate , agarose  and collagen . We report here the development of new bicomponent scaffolds based on the self-assembling peptide RAD16-I, for guiding chondrogenic differentiation of both adipose-derived stem cells (ADSC) and expanded dedifferentiated human articular chondrocytes (hAChs).
3.1 Bicomponent scaffolds made out of heparin/self-assembling peptide hydrogels
In this section, we report the development of a nanofiber scaffold with growth factor binding affinity. The strategy consisted of adding heparin moieties to the RAD16-I peptide scaffold by mixing the two components, forming a stable composite hydrogel scaffold with a natural capacity to retain HBD-containing growth factors. To evaluate the functionality of this approach for CTE applications, ADSC were cultured in the new bicomponent scaffold and induced to chondrogenic differentiation using TGFβ-1, l-ascorbic acid 2-phosphate and dexamethasone as inductors in serum-free media. 3D cultures were maintained for 4 weeks in chondrogenic or control medium, and analyzed for proteoglycan production, protein expression and mechanical properties.
During ADSC culture in the peptide scaffold RAD16-I combined with increasing concentrations of heparin (RAD/Hep), constructs cultured under chondrogenic medium—unlike constructs under control medium—became highly stained with toluidine blue, indicating a significant production of proteoglycans (Figure 2A). This result correlated with the aggrecan (
Moreover, mechanical characterization was performed over 3D chondro-induced constructs. 3D constructs, presented a storage modulus (G′) in the same order of magnitude to chicken or calf articular cartilage, but the full mechanical response of the constructs was different from native cartilage as evidenced by tan(delta) (Figure 2D).
3.2 Bicomponent scaffolds made out of chondroitin sulfate or decorin and self-assembling peptide hydrogels
The next strategy was based on mimicking the native cartilage ECM by adding chondroitin sulfate or decorin molecules to the nanofiber scaffold, generating thus chondro-favorable biochemical cues in the 3D environment. Previous work has evaluated the influence of CS to guide chondrogenesis in different hydrogel scaffolds such as chitosan , PEG , or collagen type I , but less is known about the ability of decorin to promote chondrogenesis commitment. In the present work, we studied the influence of both CS and decorin molecules on chondrogenesis in a nanometric 3D system. The capacity of these bicomponent scaffolds to foster chondrogenic differentiation was evaluated in two different scenarios: re-differentiation of expanded hAChs and induction of ADSC to chondrogenic commitment. Cells were seeded in RAD16-I/CS, RAD16-I/Dec and RAD16-I scaffold alone and maintained for 4 weeks in chondrogenic or control medium. Moreover, chondrocytes were also cultured in expansion medium, which contains GFs that could affect the fate of the 3D culture. 3D constructs were analyzed for morphology, gene and protein expression, proteoglycan synthesis and mechanical properties.
SEM images were obtained at week 4 of culture to assess cell morphology and their interaction with each scaffold (Figure 3). Articular chondrocytes cultured in expansion medium possessed a spherical morphology with possible cell-matrix interactions and thorough ECM components. Nanofibers and putative matrix components were detected on the surface of constructs cultured in control medium. Moreover, grooves with visible fibers were observed on the surface of constructs cultured in chondrogenic medium, fact that suggested the presence of secreted matrix components. On the other hand, adipose-derived stem cells under chondrogenic induction looked elongated and anchored to the scaffold surface, while nanofibers and possible ECM components synthesized by the cells were observed in control medium (Figure 3). No significant differences in cell morphology were detected between RAD, RAD/CS or RAD/Dec scaffolds in any cell type.
Chondrogenic markers expression were studied at gene and protein level in hACh 3D constructs cultured in chondrogenic and expansion medium, and compared to their 2D counterparts.
Toluidine blue staining was performed in hACh 3D constructs to qualitatively assess the production of GAGs. Constructs under chondrogenic induction became highly stained, indicating a significant production and accumulation of GAGs by the cells (Figure 4C). Constructs cultured under expansion medium showed less staining, while constructs under control medium became weakly stained.
The mechanical properties of hACh 3D constructs cultured under chondrogenic medium were assessed at week 4 by dynamic mechanical analysis (DMA) and compared to calf and chicken articular cartilage (Figure 4D). hACh constructs exhibited lower storage modulus values (G′) than did the native cartilage samples. The viscous components (G″) and the complex modulus (G*) displayed a more similar tendency to cartilage controls. Nevertheless, all samples presented G′ values higher than G″ values, indicating that the constructs were more elastic than viscous. Tan(delta) showed that 3D constructs were comparable to chicken cartilage but differed from calf cartilage.
Chondrogenic and hypertrophic markers were studied in ADSC 3D constructs in the three scaffold types and compared to 2D monolayer culture. Results show that the gene expression of
Chondro-induced ADSC produced sulfated glycosaminoglycans, as reveals the intense staining by toluidine blue (Figure 5C, up). No calcium mineralization, an indicator of hypertrophy, was detected by Von Kossa staining (Figure 5C, down).
The mechanical properties of ADSC cultured under chondrogenic conditions in RAD, RAD/CS and RAD/Dec were assessed by dynamic mechanical analysis (DMA) at week 4 (Figure 5D). The constructs presented a storage modulus (G′), viscous component (G″) and complex modulus (G*) closely related to chicken and calf cartilage. However, samples presented values of G′ much higher than G´´ so that the constructs were more elastic than viscous. Tan(delta) showed that the full mechanical response of the constructs was very similar to chicken cartilage but differed from calf cartilage.
In the present work, we aimed to induce chondrogenesis differentiation of both expanded hACh and ADSC in 3D bicomponent scaffolds made out of chondroitin sulfate or decorin and self-assembling peptide hydrogels. The expression of chondrogenic markers such as
3.3 Bicomponent scaffolds made out of PCL and self-assembling peptide hydrogels
Self-assembling peptide hydrogels provide a soft and permissive microenvironment, allowing cells to migrate, extend cellular processes and contact with other cells. Nevertheless, the use of soft hydrogels for CTE can be challenging due to its low stiffness. One approach to address this issue is the use of composite scaffolds, comprising a microscale component to increase mechanical properties and a hydrogel component (of nanoscale dimension) to promote chondrogenesis. Woven 3D poly(ε-caprolactone) (PCL) resemble native cartilage mechanical properties and, due to its high wettability, can be infiltrated with a hydrogel matrix, such as fibrin, alginate, and poly-acrylamide [43, 44, 45]. In this study, we developed a unique composite scaffold by infiltrating a 3D woven microfiber poly(ε-caprolactone) scaffold with the RAD16-I self-assembling peptide nanofiber to obtain a multi-scale functional cartilage-like tissue. The chondrogenic capacity of this new bicomponent was evaluated with expanded dedifferentiated human articular chondrocytes.
The high wettability properties of the PCL scaffold (Figure 6A) allowed to easily introduce the cells suspended in the RAD16-I peptide solution between the interweaving fibers of PCL scaffold (Figure 6B, left). Areas of RAD16-I peptide deposition could be observed within the organized woven morphology of the fiber scaffold (Figure 6B, right). Thus, cells were seeded in the composite PCL/RAD and in the two scaffolds independently, PCL and RAD, and maintained for 4 weeks in expansion, chondrogenic and control medium. 3D constructs were analyzed for morphology, gene and protein expression, proteoglycan synthesis and mechanical properties.
In order to evaluate cell morphology and their interaction with the scaffolds, SEM images of hACh cultured in PCL, PCL/RAD and RAD 3D scaffolds in expansion, control and chondrogenic medium were taken at week 4 of culture (Figure 6C). hACh seeded in PCL scaffolds looked elongated and growing on the surface of PCL fibers. Interestingly, more fibers were detected under chondrogenic induction, probably due to an increase in extracellular matrix components production by the cells. In PCL/RAD constructs, cells seemed to be attached to the PCL fibers, with a more spherical morphology than in PCL scaffold alone, while hACh in RAD scaffolds presented in general a spherical shape.
Chondrogenic and hypertrophic markers were studied at gene and protein level at week 4 of culture in 3D scaffolds and compared to 2D cultures.
The expression of
The production of sulfated glycosaminoglycans was qualitatively assessed by toluidine blue staining. Constructs under chondrogenic medium were the most strongly stained compared to expansion and control medium (Figure 7C).
Mechanical properties of the scaffolds alone and hACh 3D constructs were assessed by dynamic mechanical analysis (DMA) at week 4 of culture, and compared to chicken and calf articular cartilage (Figure 8). The elastic component (G′, storage modulus) of scaffolds and 3D cultures was significantly lower than values of chicken and calf cartilage. Regarding the viscous component (G″, loss modulus), 3D constructs differed from calf native cartilage, while only PCL cellular scaffolds presented differences with chicken cartilage. All samples presented G′ values higher than G″ values, meaning that the material was more elastic than viscous. Because the complex modulus (G*) is the sum of both components, G* basically corresponds to the elastic component in this case and it presented the same pattern as the storage modulus (G′). Concerning tan(delta), which is the full mechanical response of the material, the scaffolds and cell constructs were closely related to both native cartilages, with exception of RAD constructs in chondrogenic medium, which presented differences with calf cartilage. Moreover, differences were observed between PCL/RAD and RAD constructs under the same medium. The combination of PCL scaffold and RAD hydrogel changed their viscoelastic nature after 4 weeks of culture with hACh, since tan(delta) values of the composite were increased compared to RAD scaffolds alone. This effect was not observed between composites PCL/RAD and PCL scaffold alone.
In the present study we report the chondrogenic capacity of dedifferentiated hACh in a composite scaffold comprising a microscale woven 3D poly(ε-caprolactone) and the peptide nanofiber scaffold RAD16-I. PCL scaffold resembles native cartilage mechanical properties while the RAD16-I hydrogel provides a soft and permissive 3D environment. The expression of chondrogenic markers such as
We report evidences from our previous work which indicates the chondro-inductive capacity of newly developed biomaterials including heparin-, chondroitin sulfate-, decorin-, and poly(ε-caprolactone)-based self-assembling peptide composite scaffolds. In particular, we demonstrated that these biomimetic biomaterials fostered re-differentiation of expanded human articular chondrocytes as well as adipose-derived stem cells into chondrogenic lineage commitment. Moreover, both biological and biomechanical properties obtained of these cartilage substitutes were comparable to natural samples of chicken and calf counterparts. This clearly suggest that these newly class of biomaterials are promising for their future application in reparative and regenerative medicine platforms.
This research was supported by funding from the AO Foundation in Acute Cartilage Injury Collaborative Research Program (ACI CRP) under the project “Bioactive and biomimetic scaffolds for cartilage regeneration” (BIOCART) and OSTEOCHON3D, and grants from the NIH (AR50245, AR48852, AG15768, AR48182, AG46927).
Conflict of interest
The authors declare no conflict of interest.
|ADSCs||adipose-derived stem cells|
|BMSCs||bone marrow mesenchymal stem cells|
|CTE||cartilage tissue engineering|
|DMA||dynamic mechanical analysis|
|hACh||human articular chondrocytes|
|HBD||heparin binding domain|
|MSCs||mesenchymal stem cells|
|SAPS||self-assembling peptide scaffolds|
|SEM||scanning electron microscope|
Chung C, Burdick JA. Engineering cartilage tissue. Advanced Drug Delivery Reviews. 2008; 60(2):243-262. DOI: 10.1016/j.addr.2007.08.027
Hunziker EB. Articular cartilage repair: Basic science and clinical progress. A review of the current status and prospects. Osteoarthritis and Cartilage. 2002; 10(6):432-463. DOI: 10.1053/joca.2002.0801
Chiang H, Jiang CC. Repair of articular cartilage dafects: Review and perspectives. Journal of the Formosan Medical Association. 2009; 108(2):87-101. DOI: 10.1016/S0929-6646(09)60039-5
Castells-sala C, Recha L. Current applications of tissue engineering in biomedicine, Journal of Biochips & Tissue Chips. 2015; s2:004. DOI: 10.4172/2153-0777.S2-004
Cucchiarini M, Madry H, Guilak F, Saris DB, Stoddart MJ, Koon Wong M, et al. A vision on the future of articular cartilage repair. European Cells & Materials. 2014; 27(Suppl):12-16. DOI: 10.22203/eCM
Hubka KM, Dahlin RL, Meretoja VV, Kasper FK, Mikos AG. Enhancing chondrogenic phenotype for cartilage tissue engineering: Monoculture and coculture of articular chondrocytes and mesenchymal stem cells. Tissue Engineering. Part B, Reviews. 2014; 20(6):641-654. DOI: 10.1089/ten.teb.2014.0034
Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284(5411):143-147. DOI: 10.1126/science.284.5411.143
Darling EM, Athanasiou KA. Rapid phenotypic changes in passaged articular chondrocyte subpopulations. Journal of Orthopaedic Research. 2006; 23(2):425-432. DOI: 10.1016/j.orthres.2004.08.008
Hong E, Reddi AH. Dedifferentiation and redifferentiation of articular chondrocytes from surface and middle zones: Changes in MICRORNAS-221/-222, -140, and -143/145 expression. Tissue Engineering. Part A. 2012; 19(7-8):1015-1022. DOI: 10.1089/ten.tea.2012.0055
Griffith LG, Swartz MA. Capturing complex 3D tissue physiology in vitro. Nature Reviews. Molecular Cell Biology. 2006; 7(3):211-224. DOI: 10.1038/nrm1858
Lee S-H, Shin H. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. Advanced Drug Delivery Reviews. 2007; 59(4):339-359. DOI: 10.1016/j.addr.2007.03.016
Fischbach C, Chen R, Matsumoto T, Schmelzle T, Brugge JS, Polverini PJ, et al. Engineering tumors with 3D scaffolds. Nature Methods. 2007; 4(10):855-860. DOI: 10.1038/nmeth1085
Horning JL, Sahoo SK, Vijayaraghavalu S, Dimitrijevic S, Vasir JK, Jain TK, et al. 3-D tumor model for in vitro evaluation of anticancer drugs. Molecular Pharmaceutics. 2008; 5(5):849-862. DOI: 10.1021/mp800047v
Sahoo SK, Panda AK, Labhasetwar V. Characterization of porous PLGA/PLA microparticles as a scaffold for three dimensional growth of breast cancer cells. Biomacromolecules. 2005; 6(2):1132-1139. DOI: 10.1021/bm0492632
Schneider JP, Pochan DJ, Ozbas B, Rajagopal K, Pakstis L, Kretsinger J. Responsive hydrogels from the intramolecular folding and self-assembly of a designed peptide. Journal of the American Chemical Society. 2002; 124(50):15030-15037. DOI: 10.1021/ja027993g
Genové E, Shen C, Zhang S, Semino CE. The effect of functionalized self-assembling peptide scaffolds on human aortic endothelial cell function. Biomaterials. 2005; 26(16):3341-3351. DOI: 10.1016/j.biomaterials.2004.08.012
Semino CE. Self-assembling peptides: From bio-inspired materials to bone regeneration. Journal of Dental Research. 2008; 87(7):606-616. DOI: 10.1177/154405910808700710
Semino CE. Can we build artificial stem cell compartments ? 2003; 3:164-169. DOI: 10.1155/S1110724303208019
Elsa G, Stephanie S, Ana S, Salvador B, Augustinus B, Griffith LG, et al. Functionalized self-assembling peptide hydrogel enhance maintenance of hepatocyte activity in vitro. Journal of Cellular and Molecular Medicine. 2009; 13(9b):3387-3397. DOI: 10.1111/j.1582-4934.2009.00970.x
Sieminski AL, Semino CE, Gong H, Kamm RD. Primary sequence of ionic self-assembling peptide gels affects endothelial cell adhesion and capillary morphogenesis. Journal of Biomedical Materials Research Part A. 2008; 87(2):494-504. DOI: 10.1002/jbm.a.31785
Wu J, Marí-Buyé N, Muiños TF, Borrós S, Favia P, Semino CE. Nanometric self-assembling peptide layers maintain adult hepatocyte phenotype in sandwich cultures. Journal of Nanobiotechnology. 2010; 8(1):29. DOI: 10.1186/1477-3155-8-29
Dégano IR, Quintana L, Vilalta M, Horna D, Rubio N, Borrós S, et al. The effect of self-assembling peptide nanofiber scaffolds on mouse embryonic fibroblast implantation and proliferation. Biomaterials. 2009; 30(6):1156-1165. DOI: 10.1016/j.biomaterials.2008.11.021
Garreta E, Genové E, Salvador B, Semino CE. Osteogenic differentiation of mouse embryonic stem cells and mouse embryonic fibroblasts in a three-dimensional self-assembling peptide scaffold. Tissue Engineering. 2006; 12(8):2215-2227. DOI: 10.1089/ten.2006.12.2215
Castells-Sala C, Recha-Sancho L, Llucià-Valldeperas A, Soler-Botija C, Bayes-Genis A, Semino CE. Three-dimensional cultures of human subcutaneous adipose tissue-derived progenitor cells based on RAD16-I self-assembling peptide. Tissue Engineering. Part C, Methods. 2016; 22(2):ten.tec.2015.0270. DOI: 10.1089/ten.tec.2015.0270
Fernández-Muiños T, Recha-Sancho L, López-Chicón P, Castells-Sala C, Mata A, Semino CE. Bimolecular based heparin and self-assembling hydrogel for tissue engineering applications. Acta Biomaterialia. 2015; 16(1):35-48. DOI: 10.1016/j.actbio.2015.01.008
Chen W-C, Yao C-L, Chu I-M, Wei Y-H. Compare the effects of chondrogenesis by culture of human mesenchymal stem cells with various type of the chondroitin sulfate C. Journal of Bioscience and Bioengineering. 2011; 111(2):226-231. DOI: 10.1016/j.jbiosc.2010.10.002
Seidler DG, Dreier R. Decorin and its galactosaminoglycan chain: Extracellular regulator of cellular function? IUBMB Life. 2008; 60(11):729-733. DOI: 10.1002/iub.115
Trowbridge JM, Gallo RL. Dermatan sulfate: New functions from an old glycosaminoglycan. Glycobiology. 2002; 12(9):117R-125R. DOI: 10.1093/glycob/cwf066
Moutos FT, Freed LE, Guilak F. A biomimetic three-dimensional woven composite scaffold for functional tissue engineering of cartilage. Nature Materials. 2007; 6:162. DOI: 10.1038/nmat1822
Huang M-H, Li S, Hutmacher DW, Coudane J, Vert M. Degradation characteristics of poly(ϵ-caprolactone)-based copolymers and blends. Journal of Applied Polymer Science. 2006; 102(2):1681-1687. DOI: 10.1002/app.24196
Rohner D, Hutmacher DW, Cheng TK, Oberholzer M, Hammer B. In vivo efficacy of bone-marrow-coated polycaprolactone scaffolds for the reconstruction of orbital defects in the pig. Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2003; 66B(2):574-580. DOI: 10.1002/jbm.b.10037
Freed LE, Engelmayr GC, Borenstein JT, Moutos FT, Guilak F.Advanced material strategies for tissue engineering scaffolds. Advanced Materials. 2009; 21(32-33):3410-3418. DOI: 10.1002/adma.200900303
Baugé C, Girard N, Lhuissier E, Bazille C, Boumediene K. Regulation and role of TGFβ signaling pathway in aging and osteoarthritis joints. Aging and Disease. 2014; 5(6):394-405. DOI: 10.14336/AD.2014.0500394
Cals FLJ, Hellingman CA, Koevoet W, Baatenburg de Jong RJ, van Osch GJVM. Effects of transforming growth factor-β subtypes on in vitro cartilage production and mineralization of human bone marrow stromal-derived mesenchymal stem cells. Journal of Tissue Engineering and Regenerative Medicine. 2011; 6(1):68-76. DOI: 10.1002/term.399
Chen WH, Lai MT, Wu ATH, Wu CC, Gelovani JG, Lin CT, et al. In vitro stage-specific chondrogenesis of mesenchymal stem cells committed to chondrocytes. Arthritis and Rheumatism. 2009; 60(2):450-459. DOI: 10.1002/art.24265
Chung C, Burdick JA. Engineering cartilage tissue. Advanced Drug Delivery Reviews. 2008; 60(2):243-262. DOI: 10.1016/j.addr.2007.08.027
Awad HA, Wickham MQ , Leddy HA, Gimble JM, Guilak F. Chondrogenic differentiation of adipose-derived adult stem cells in agarose, alginate, and gelatin scaffolds. Biomaterials. 2004; 25(16):3211-3222. DOI: 10.1016/j.biomaterials.2003.10.045
Masuoka K, Asazuma T, Hattori H, et al. Tissue engineering of articular cartilage with autologous cultured adipose tissue-derived stromal cells using atelocollagen honeycomb-shaped scaffold with a membrane sealing in rabbits. Journal of Biomedical Materials Research. Part B, Applied Biomaterials. 2006; 79(1):25-34. DOI: 10.1002/jbmb
Sechriest VF, Miao YJ, Niyibizi C, Westerhausen-Larson A, Matthew HW, Evans CH, et al. GAG-augmented polysaccharide hydrogel: A novel biocompatible and biodegradable material to support chondrogenesis. Journal of Biomedical Materials Research. 2000; 49(4):534-541. DOI: 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
Varghese S, Hwang NS, Canver AC, Theprungsirikul P, Lin DW, Elisseeff J. Chondroitin sulfate based niches for chondrogenic differentiation of mesenchymal stem cells. Matrix Biology. 2008; 27(1):12-21. DOI: 10.1016/j.matbio.2007.07.002
Mullen LM, Best SM, Ghose S, Wardale J, Rushton N, Cameron RE. Bioactive IGF-1 release from collagen–GAG scaffold to enhance cartilage repair in vitro. Journal of Materials Science. Materials in Medicine. 2015; 26(1):1-8. DOI: 10.1007/s10856-014-5325-y
Recha-Sancho L, Semino CE. Chondroitin sulfate- and decorin-based self-Assembling scaffolds for cartilage tissue engineering. PLoS One. 2016; 11(6):1-23. DOI: 10.1371/journal.pone.0157603
Valonen PK, Moutos FT, Kusanagi A, Moretti MG, Diekman BO, Welter JF, et al. In vitro generation of mechanically functional cartilage grafts based on adult human stem cells and 3D-woven poly(ɛ-caprolactone) scaffolds. Biomaterials. 2010; 31(8):2193-2200. DOI: 10.1016/j.biomaterials.2009.11.092
Moutos FT, Guilak F. Functional properties of cell-seeded three-dimensionally woven poly(ε-caprolactone) scaffolds for cartilage tissue engineering. Tissue Engineering. Part A. 2009; 16(4):1291-1301. DOI: 10.1089/ten.tea.2009.0480
Liao I-C, Moutos FT, Estes BT, Zhao X, Guilak F. Composite three-dimensional woven scaffolds with interpenetrating network hydrogels to create functional synthetic articular cartilage. Advanced Functional Materials. 2013; 23(47):5833-5839. DOI: 10.1002/adfm.201300483
Recha-Sancho L, Moutos FT, Abellà J, Guilak F, Semino CE. Dedifferentiated human articular chondrocytes redifferentiate to a cartilage-like tissue phenotype in a poly(ε-caprolactone)/Self-assembling peptide composite scaffold. Materials. 2016; 9(6). DOI: 10.3390/ma9060472